Metallopanstimulin / S27 ribosomal antigen expression in stages I and II breast cancer: Its relationship with clinicopathologic factors

Cancer Genomics and Proteomics

Volumn 2, Issue 1, 2005, Pages 53-60

  Sundblad, Alberto S ^a   Ricci, Lila ^b   Xynos, Francisco P ^a   Fernandez Pol, J Alberto ^c  

^a HOSPITAL PRIVADO DE COMUNIDAD   (Argentina)

^b UNIVERSIDAD NACIONAL DE MAR DEL PLATA   (Argentina)

^c Metalloproteomics   (United States)

Author keywords

Breast carcinoma; Metallopanstimulin; Ribosomal protein S27; Zinc finger proteins

Indexed keywords

BIOLOGICAL MARKER; ESTROGEN RECEPTOR; KI 67 ANTIGEN; METALLOPANSTIMULIN; METALLOPANSTIMULIN ANTIBODY; PROGESTERONE RECEPTOR; PROTEIN ANTIBODY; RIBOSOME PROTEIN; RIBOSOME PROTEIN S27; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER GRADING; CANCER GROWTH; CANCER RECURRENCE; CANCER SURVIVAL; CELL PROLIFERATION; CORRELATION ANALYSIS; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; METASTASIS; PROGNOSIS; RIBOSOME SUBUNIT; TUMOR VOLUME;

EID: 20344405507     PISSN: 11096535     EISSN: 17906245     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Rosen PP, Groshan S, Kinne DW et al: Factors influencing prognosis in node-negative breast carcinoma: Analysis of 767 T1N0M0/T2N0M0 patients with long-term follow up. J Clin Onco 11: 2090-2100, 1993.
2. Henderson IC: Adjuvant chemotherapy for early breast cancer. Br J Cancer 61: 652-654, 1990.
3. De Mascarel I, Soubeyran I, MacGrogan G, Wafflart J, Bonichon F, Durand M, Avril A, Mauriac L, Trojani M and Coindre JM: Immunohistochemical analysis of estrogen receptors in 938 breast carcinomas. Appl Immunohistochem 3: 222-231, 1995.4.
4. MacGrogan G, Soubeyran, I, De Mascarel I, Wafflart J, Bonichon F, Durand M, Avril, A, Mauriac L, Trojani M and Coindre JM: Immunohistochemical detection of progesterone receptors in breast invasive ductal carcinomas. Appl Immunohistochem 4: 219-227, 1996.
5. Battifora H, Gaffey M, Esteban J, Mehta P, Bailey A, Faucett C and Niland J: Immunohistochemical assay of neu/c-erbB-2 oncogene product in paraffin-embedded tissues in early breast cancer. Retrospective follow-up study of 245 stage I and II cases. Mod Pathol 4: 466-474, 1991.
6. Sundblad AS, Pellicer EM and Ricci L: Carcinoembryonic antigen expression in stages I and II breast cancer: Its relationship with clinicopathologic factors. Hum Pathol 27: 297-301, 1996.
7. Barbareschi M: Prognostic value of the immunohistochemical expression of p53 in breast carcinomas. A review of the literature involoving over 9,000 patients. Appl Immunohistochem 4: 106-116, 1996.
8. Weidner N, Moore DH and Vartanian R: Correlation of Ki-67 antigen expression with mitotic figure index and tumor grade in breast carcinomas using the novel "paraffin"-reactive MIB-1 antibody. Hum Pathol 25: 337-342, 1994.
9. Joensuu H, Pylkkanen L and Toikkanen S: Bcl-2 protein expression and long-term survival in breast cancer. Am J Pathol 145: 1191-1198, 1994.
10. Fernandez-Pol JA: Modulation of EGF receptor protooncogene expression by growth factors and hormones in human breast carcinoma cells. CRC Critical Reviews in Oncogenesis 1991, Vol 2, pp 173-185.
11. Fernandez-Pol JA, Klos DJ and Hamilton PD: A Growth Factor-inducible gene encodes a novel nuclear protein with zinc-finger structure. J Biol Chem 268: 21198-204, 1993.
12. Fernandez-Pol JA, Klos DJ and Hamilton PD: Metallopanstimulin gene product produced in a Baculovirus expression system is a nuclear phosphoprotein that binds to DNA. Cell Growth & Differentiation 5: 811-825, 1994.
13. Ganger DR, Hamilton PD, Klos DJ, Jakate S, McChesney L and Fernandez-Pol JA: Differential Expression of Metallopanstimulin/S27 ribosomal protein in hepatic regeneration and neoplasia. Cancer Defection and Prevention 25: 241-246, 2001.
14. Fernandez-Pol JA: Metallopanstimulin as a Novel tumor marker in sera of patients with various types of common cancers: Implications for prevention and therapy. Anticancer Res 16: 2177-86, 1996.
15. Fernandez-Pol JA, Fletcher JW, Hamilton PD and Klos DJ: Expression of Metallopanstimulin and oncogenesis in human prostatic carcinoma. Anticancer Research 17: 1519-1530, 1997.
16. Fernandez-Pol JA, Hamilton PD and Klos DJ: Essential viral and cellular zinc and iron containing metalloproteins as targets for novel antiviral and anticancer agents: Implications for prevention and therapy of viral diseases and cancer. Anticancer Res 21: 931-57, 2001.
17. Fernandez-Pol JA and Douglas MG: Molecular Interactions of Cancer and Age. In: Balducci L and Extermann M (eds) Cancer in the elderly, current concepts and future directions. Hematology/Oncology Clinics of North America, Saunders WB Co, Philadelphia, 2000, Vol 14, No. 1, pp. 25-44.
18. Stack BC Jr, Dalsaso TA, Lee C, Lowe VJ, Hamilton PD, Fletcher JW and Fernandez-Pol JA: Overexpression of MPS antigens by squamous cell carcinomas of the head and neck: Immunohistochemistry and Serological correlation with FDG positron emission tomography. Anticancer Res 19: 5503-5510, 1999.
19. Santa Cruz DJ, Hamilton PD, Klos DJ and Fernandez-Pol JA: Differential expression of metallopanstimulin/S27 ribosomal protein in melanocytic lesions of the skin. J of Cutaneous Pathology 24: 533-542, 1997.
20. Fernandez-Pol JA: Growth Factors, Oncogenes and Aging. In: Comprehensive Geriatric Oncology: Balducci L, Lyman GH, Henderson CC, and Ershler, WB (eds), Harwood Academic Publishers, 1997, pp 179-196.
21. Revenkova E, Masson J, Koncz C, Koncz C, Alfasar K, Jakovleva and Paszkowski J: Involvement of Arabidopsis thaliana ribosomal protein S27 in mRNA degradation triggered by genotoxic strees. The EMBO Journal 18: 101-110, 1999.
22. Atsuka Y, Aoki N, Sato K, Oikawa K, Nochi H, Miyokawa N, Hirata S, Kimura S, Sasajima T and Katagiri M: Identification of metallopanstimulin-1 as a member of a tumor associated antigen in patients with breast cancer. Cancer Letters 182: 101-107, 2002.
23. McGuire WL and Clark GM: Prognostic factors and treatment decisions in axillary-node-negative breast cancer. N Engl J Med 326: 1756-1761, 1992.
24. Millon R, Nicora F, Muller D, Erber M, Klein-Soyer C and Abecassis J: Modulation of human breast cancer cell adhesion by estrogens and antiestrogens. Clinical & Experimental Metastasis 7: 405-415, 1989.
25. Battifora H: Assessment of antigen damage in immunohistochemistry: The vimentin internal control. Am J Clin Pathol 96: 669-617, 1991.
26. Chan Y-L, Olvera J, Paz V and Wool IG: The primary structures of rat ribosomal proteins S3a (The v-fos transformation effector) and of S3b. Biochem and Biophys Res Comm 228: 141-147, 1996.
27. Chan Y-L, Diaz J-J, Denoroy L, Madjar J-J and Wool IG: The primary structure of rat ribosomal protein L10: Relationship to a Jun-binding protein and to a putative Wilms' tumor suppressor. Biochem and Biophys Res. Comm 225: 952-956, 1996.
28. Wool IG: Extraribosomal Functions of Ribosomal Proteins. Trends in Biochemical Sciences 21: 165-165, 1996.
29. Wool IG: Extraribosomal functions of ribosomal proteins. In: Ribosomal RNA and Group I Introns: R Green and R Schroeder (Eds.), publishers: R. G. Landes Co, Austin, TX, USA, 1997, pp153-178.
30. Wool IG, Chan Y-L and Gluck A: Structure and Evolution of mammalian ribosomal proteins. Biochemistry & Cell Biology 73: 933-947, 1995.
31. Vaarala M, Porvari KS, Kyllonen AP, Mustonen MVJ, Kukkarinen O and Vihko PT: Several genes encoding ribosomal proteins are over-expressed in prostate-cancer cell lines: Confirmation of L7a and L37 over-expression in prostate cancer tissue samples. Int J Cancer 78: 27-32, 1998.